ArticleCancer research communications2021

HSP70 inhibition blocks adaptive resistance and synergizes with MEK inhibition for the treatment of NRAS-mutant melanoma.

Joshua L D Parris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.